1. Tavassoli FA, Schnitt SJ, Hoefler H, Bocker W, Rosai J, Heywang-Kobrunner SH, Holland R, Monifar F, Ellis IO, Lakhani SR: Intraductal proliferative lesions. Tavassoli FA, Devilee P eds. Tumor of the breast and female genital organs. World Health Organization Classification of Tumours. IARC Press, Lyon, pp63–73, 2003.
2. Ernster VL, Barclay J, Kerlikowske K, Wilkie H, Ballard-Barbash R: Mortality among women with ductal carcinoma in situ of the breast in the populationbased surveillance, epidemiology and end results program. Arch Int Med 953–958, 2000.
3. Bernstein L: The epidemiology of breast carcinoma in situ. In Ductal carcinoma in situ. 2 nd. Ed., Silverstein MJ, ed. Lippincott Williams and Wilkins, Philadelphia, pp22–34, 2002.
4. Izuo M: Noninvasive ductal carcinoma of the breast. Current status and problems.Jpn J Breast Cancer 10:47–60, 1995 (In Japanese).
5. Moriya T, Kasami M, Akiyama F, Ichihara S, Kurosumi M, Tsuda H, Umemura S, Akashi-Tanaka S, Imamura H, Iwase H, Shin E, Harada Y, Ohuchi N: A proposal for histopathological diagnosis of ductal carcinoma in situ of the breast.Breast Cancer 7:321–325, 2000.